Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse |
| |
Authors: | Abbate Antonio Salloum Fadi N Van Tassell Benjamin W Vecile Elena Toldo Stefano Seropian Ignacio Mezzaroma Eleonora Dobrina Aldo |
| |
Institution: | Victoria Johnson Research Laboratory and VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America. aabbate@mcvh-vcu.edu |
| |
Abstract: | BackgroundHealing after acute myocardial infarction (AMI) is characterized by an intense inflammatory response and increased Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-, not responsive to IL-1) or the IL-1 receptor antagonist (IL-1Ra, enhanced response to IL-1) have an altered IL-1/IL-1Ra balance that we hypothesize modulates infarct healing and cardiac remodeling after AMI.MethodsIL-1R1-/- and IL-1Ra-/- male mice and their correspondent wild-types (WT) were subjected to permanent coronary artery ligation or sham surgery. Infarct size (trichrome scar size), apoptotic cell death (TUNEL) and left ventricular (LV) dimensions and function (echocardiography) were measured prior to and 7 days after surgery.ResultsWhen compared with the corresponding WT, IL-1R1-/- mice had significantly smaller infarcts (?25%), less cardiomyocyte apoptosis (?50%), and reduced LV enlargement (LV end-diastolic diameter increase LVEDD], ?20%) and dysfunction (LV ejection fraction LVEF] decrease, ?50%), whereas IL-1Ra-/- mice had significantly larger infarcts (+75%), more apoptosis (5-fold increase), and more severe LV enlargement (LVEDD increase,+30%) and dysfunction (LVEF decrease, +70%)(all P values <0.05).ConclusionsAn imbalance in IL-1/IL-1Ra signaling at the IL-1R1 level modulates the severity of cardiac remodeling after AMI in the mouse, with reduced IL-1R1 signaling providing protection and unopposed IL-1R1 signaling providing harm. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|